 | • レポートコード：MRC-IM30344 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年15億ドルであった世界のキャリアスクリーニング市場規模が2027年には29億ドルに達し、予測期間中、年平均11.4％成長すると予測しています。本調査レポートでは、キャリアスクリーニングの世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（拡張キャリアスクリーニング、対象疾患キャリアスクリーニング）分析、疾患別（肺疾患、血液疾患、神経疾患、その他）分析、技術別（DNAシークエンシング、ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、その他）分析、エンドユーザー別（病院・診療所、参考検査室、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Fulgent Genetics, Gene By Gene Ltd. (MyDNA), Illumina Inc., Invitae Corporation, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Quest Diagnostics, Sema4などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のキャリアスクリーニング市場規模：種類別 - 拡張キャリアスクリーニングの市場規模 - 対象疾患キャリアスクリーニングの市場規模 ・世界のキャリアスクリーニング市場規模：疾患別 - 肺疾患における市場規模 - 血液疾患における市場規模 - 神経疾患における市場規模 - その他疾患における市場規模 ・世界のキャリアスクリーニング市場規模：技術別 - DNAシークエンシングにおける市場規模 - ポリメラーゼ連鎖反応（PCR）における市場規模 - マイクロアレイにおける市場規模 - その他キャリアスクリーニングの市場規模 ・世界のキャリアスクリーニング市場規模：エンドユーザー別 - 病院・診療所における市場規模 - 参考検査室における市場規模 - その他エンドユーザーにおける市場規模 ・世界のキャリアスクリーニング市場規模：地域別 - 北米のキャリアスクリーニング市場規模 - アジアのキャリアスクリーニング市場規模 - 欧州のキャリアスクリーニング市場規模 - 中南米のキャリアスクリーニング市場規模 - 中東・アフリカのキャリアスクリーニング市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global carrier screening market size reached US$ 1.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2027, exhibiting a growth rate (CAGR) of 11.4% during 2022-2027.
Carrier screening is a genetic testing technique used for the identification abnormal genes in fetuses that can cause autosomal recessive diseases. It is a predictive and pre-symptomatic testing solution used by pregnant individuals and couples to analyze the risks of their child inheriting genetic disorders from the parents. It involves testing a sample of saliva, blood or cheek tissue to detect the presence of an abnormal gene for disorders, such as cystic fibrosis, sickle cell anemia and Tay-Sachs disease. These samples are screened through molecular and biochemical processes based on deoxyribonucleic acid (DNA) sequencing, polymerase chain reaction (PCR) and microarray technologies. They are used for expanded, customized panel, predesigned panel and targeted disease carrier screening for various pulmonary, hematological and neurological disorders.
Carrier Screening Market Trends:
The increasing prevalence of fetal chromosomal abnormalities and genetic disorders across the globe is one of the key factors driving the growth of the market. Moreover, the rising consciousness among the masses regarding the benefits of early detection and diagnosis of diseases is providing a thrust to the market growth. In line with this, molecular screening tests are widely conducted to identify DNA mutations in the genetic codes and detect the mutations that can cause heart defects, pre-leukemia, hearing defects and down syndrome. Carrier screening also aids in providing adequate prenatal and reproductive care, which facilitates the proper management of heritable diseases. Additionally, various technological advancements, such as the development of next-generation sequencing (NGS) techniques for genetic disease screening, are also favoring the market growth. Other factors, including extensive research and development (R&D) activities in the field of biotechnology and bioinformatics, along with significant growth in the medical infrastructure, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global carrier screening market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, medical condition, technology and end user.
Breakup by Type:
Expanded Carrier Screening
Customized Panel Testing
Predesigned Panel Testing
Targeted Disease Carrier Screening
Breakup by Medical Condition:
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Others
Breakup by Technology:
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Others
Breakup by End User:
Hospitals and Clinics
Reference Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Fulgent Genetics, Gene By Gene Ltd. (MyDNA), Illumina Inc., Invitae Corporation, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Quest Diagnostics, Sema4 and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global carrier screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global carrier screening market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the medical condition?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global carrier screening market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Carrier Screening Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Expanded Carrier Screening
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Customized Panel Testing
6.1.2.2 Predesigned Panel Testing
6.1.3 Market Forecast
6.2 Targeted Disease Carrier Screening
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Medical Condition
7.1 Pulmonary Conditions
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hematological Conditions
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurological Conditions
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Technology
8.1 DNA Sequencing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Polymerase Chain Reaction
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Microarrays
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals and Clinics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Reference Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Fulgent Genetics
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Gene By Gene Ltd. (MyDNA)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Illumina Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Invitae Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 MedGenome Labs Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Myriad Genetics Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Natera Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 OPKO Health Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Quest Diagnostics
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sema4
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Figure 2: Global: Carrier Screening Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Carrier Screening Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Carrier Screening Market: Breakup by Type (in %), 2021
Figure 5: Global: Carrier Screening Market: Breakup by Medical Condition (in %), 2021
Figure 6: Global: Carrier Screening Market: Breakup by Technology (in %), 2021
Figure 7: Global: Carrier Screening Market: Breakup by End User (in %), 2021
Figure 8: Global: Carrier Screening Market: Breakup by Region (in %), 2021
Figure 9: Global: Carrier Screening (Expanded Carrier Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Carrier Screening (Expanded Carrier Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Carrier Screening (Targeted Disease Carrier Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Carrier Screening (Targeted Disease Carrier Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Carrier Screening (Pulmonary Conditions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Carrier Screening (Pulmonary Conditions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Carrier Screening (Hematological Conditions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Carrier Screening (Hematological Conditions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Carrier Screening (Neurological Conditions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Carrier Screening (Neurological Conditions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Carrier Screening (Other Medical Conditions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Carrier Screening (Other Medical Conditions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Carrier Screening (DNA Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Carrier Screening (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Carrier Screening (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Carrier Screening (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Carrier Screening (Microarrays) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Carrier Screening (Microarrays) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Carrier Screening (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Carrier Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Carrier Screening (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Carrier Screening (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Carrier Screening (Reference Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Carrier Screening (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Carrier Screening (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Carrier Screening (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: North America: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: North America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: United States: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Canada: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Canada: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Asia-Pacific: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Asia-Pacific: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: China: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: China: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Japan: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Japan: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: South Korea: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: South Korea: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Australia: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Australia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Indonesia: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Indonesia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Europe: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Europe: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Germany: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Germany: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: France: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: France: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: United Kingdom: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: United Kingdom: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Italy: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Italy: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Spain: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Spain: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Russia: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Russia: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Latin America: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Latin America: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Brazil: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Brazil: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Mexico: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Mexico: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Middle East and Africa: Carrier Screening Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Middle East and Africa: Carrier Screening Market: Breakup by Country (in %), 2021
Figure 83: Middle East and Africa: Carrier Screening Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Global: Carrier Screening Industry: SWOT Analysis
Figure 85: Global: Carrier Screening Industry: Value Chain Analysis
Figure 86: Global: Carrier Screening Industry: Porter's Five Forces Analysis
• 日本語訳：キャリアスクリーニングの世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30344 ▷ お問い合わせ（見積依頼・ご注文・質問）